SLNO Operating Cash Flow (Statement)
Soleno Therapeutics Inc · Operating Cash Flow (Statement)
SLNO Operating Cash Flow (Statement)
Latest reported$25.98Mperiod ending
SLNO Quarterly Cash from Operations ($2.08M → $25.98M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
SLNO operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 25,980,000 | |
| 48,704,000 | |
| 43,632,000 | |
| -12,608,000 | |
| -32,752,000 | |
| -23,991,000 | |
| -14,926,000 | |
| -17,651,000 | |
| -12,528,000 | |
| -6,314,000 | |
| -6,332,000 | |
| -5,566,000 | |
| -6,728,000 | |
| -5,143,000 | |
| -4,656,000 | |
| -4,620,000 | |
| -6,362,000 | |
| -6,863,000 | |
| -5,406,000 | |
| -8,013,000 | |
| -7,488,000 | |
| -6,867,000 | |
| -6,164,000 | |
| -6,534,000 | |
| -5,659,000 | |
| -5,076,000 | |
| -4,719,000 | |
| -3,893,000 | |
| -3,687,000 | |
| -3,736,000 | |
| -2,677,000 | |
| -2,750,000 | |
| -2,520,000 | |
| -2,731,958 | |
| -2,271,000 | |
| -2,764,000 | |
| -2,183,000 | |
| -2,687,980 | |
| -2,786,000 | |
| -4,040,000 | |
| -3,984,000 | |
| -3,378,330 | |
| -2,861,000 | |
| -2,251,000 | |
| -1,809,000 | |
| -1,556,362 | |
| -1,262,230 | |
| -1,156,411 | |
| -509,359 | |
| -722,218 | |
| -924,086 | |
| -1,323,809 | |
| 2,084,895 |